Diabetologia highlights a study of the new oral GLP-1 receptor agonist, which the journal says showed encouraging efficacy and safety results.
Recap by typeshit. Post by Diabetologia on X.
A professor walks through peptides as short amino acid chains and their roles in cell signaling and regulation.
A Mayo Clinic Florida study of over 3,800 women found 9.8% vs 8.2% weight loss at 9 months with HT on semaglutide. Researchers say it shows association, not cause.
Stanford doctors look at what peptides are and whether the online wellness hype holds up, covering possible upsides alongside the risks.
His GLP-1 series turns to heart failure with preserved ejection fraction, where the heart pumps normally but struggles to relax and fill.
In an ADJUST-T1D follow-up, former semaglutide users lost a median 3.6 points of time in range within 3 months, even while on automated insulin delivery.
With retatrutide trials showing losses near 29%, doctors quoted by Medscape describe when weight loss may be going too far and lost strength calls for a rethink.
Loading…